FDA issues Class 2 recall of InterStim SureScan device
FDA action · FDA · 2026-10-22. Number 5 in the UrologyWatch Top 5 for October 24, 2026.
FDA has issued a Class 2 recall for the InterStim SureScan sacral neuromodulation system; specific defect and affected lots are detailed in the recall notice.
Why it matters: Providers implanting or following patients with InterStim SureScan devices should review the recall details for affected units.
Source: FDA
Loading today's edition…